{"id":"prasugrel-loading","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Bleeding (major and minor)"},{"rate":"<0.1","effect":"Thrombotic thrombocytopenic purpura (TTP)"},{"rate":"1-2","effect":"Dyspnea"},{"rate":"1-2","effect":"Bradycardia"}]},"_chembl":{"chemblId":"CHEMBL1201772","moleculeType":"Small molecule","molecularWeight":"373.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prasugrel is a prodrug that requires hepatic metabolism to form its active metabolite, which then binds irreversibly to the P2Y12 receptor on platelet surfaces. This blocks ADP-mediated platelet activation and aggregation, reducing thrombotic events. The loading dose is administered acutely to rapidly achieve antiplatelet effects in acute coronary syndrome patients.","oneSentence":"Prasugrel is a thienopyridine antiplatelet agent that irreversibly inhibits the P2Y12 adenosine diphosphate receptor on platelets, preventing platelet aggregation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:02:03.084Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (ACS) including unstable angina, non-ST elevation myocardial infarction (NSTEMI), and ST elevation myocardial infarction (STEMI) managed with percutaneous coronary intervention (PCI)"}]},"trialDetails":[{"nctId":"NCT04014803","phase":"PHASE4","title":"Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2020-01-13","conditions":"Coronary Artery Disease","enrollment":3500},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT01777503","phase":"PHASE4","title":"The Elderly ACS II Trial","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2012-11","conditions":"Acute Coronary Syndrome, Coronary Arteriosclerosis, Myocardial Ischemia","enrollment":1457},{"nctId":"NCT03606642","phase":"PHASE2","title":"SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2018-11-19","conditions":"Coronary Artery Disease, Atherosclerosis, Stent Placement","enrollment":50},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06484647","phase":"","title":"Comparing T-stenting And Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation","status":"RECRUITING","sponsor":"San Luigi Gonzaga Hospital","startDate":"2024-06-01","conditions":"Coronary Artery Disease, Ischemic Heart Disease, Chronic Coronary Syndrome","enrollment":382},{"nctId":"NCT02016170","phase":"NA","title":"Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-03","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":82},{"nctId":"NCT05779059","phase":"PHASE3","title":"Prasugrel Or Ticagrelor De-escalation in NSTE-ACS","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2023-04-01","conditions":"Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina","enrollment":50},{"nctId":"NCT04766437","phase":"PHASE2","title":"Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-02-19","conditions":"Non ST Segment Elevation Acute Coronary Syndrome","enrollment":75},{"nctId":"NCT01944800","phase":"PHASE4","title":"Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2013-09-15","conditions":"Acute Coronary Syndrome (ACS)","enrollment":4018},{"nctId":"NCT05247385","phase":"PHASE4","title":"Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-03-20","conditions":"Coronary Artery Disease","enrollment":87},{"nctId":"NCT03296540","phase":"PHASE4","title":"CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI","status":"COMPLETED","sponsor":"Maasstad Hospital","startDate":"2017-11-28","conditions":"Cardiovascular Diseases","enrollment":729},{"nctId":"NCT04768582","phase":"NA","title":"Platelet Reactivity After an Eastern Asian Loading Dose of Prasugrel in Taiwanese ACS Patients","status":"UNKNOWN","sponsor":"Feng Yuan Hospital, Ministry of Health and Welfare","startDate":"2020-05-01","conditions":"Acute Coronary Syndrome, Hemorrhage, Treatment Side Effects","enrollment":45},{"nctId":"NCT04734353","phase":"PHASE4","title":"Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)","status":"UNKNOWN","sponsor":"Gyeongsang National University Hospital","startDate":"2020-01-15","conditions":"Coronary Artery Disease","enrollment":492},{"nctId":"NCT02618837","phase":"PHASE4","title":"Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2015-12-14","conditions":"Unstable Angina or Non ST Elevated Myocardial Infarction","enrollment":2520},{"nctId":"NCT03489863","phase":"PHASE4","title":"Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2018-05-30","conditions":"Coronary Artery Disease","enrollment":14},{"nctId":"NCT01365221","phase":"PHASE4","title":"The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2010-10","conditions":"Acute Coronary Syndrome","enrollment":77},{"nctId":"NCT02944123","phase":"PHASE3","title":"Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2016-09","conditions":"Acute Coronary Syndrome","enrollment":120},{"nctId":"NCT02548611","phase":"PHASE4","title":"Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention","status":"TERMINATED","sponsor":"LMU Klinikum","startDate":"2015-09","conditions":"Angina Pectoris","enrollment":795},{"nctId":"NCT04445623","phase":"PHASE3","title":"Prasugrel in Severe COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2020-07","conditions":"COVID19, Thrombosis","enrollment":128},{"nctId":"NCT02247128","phase":"PHASE4","title":"Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2014-01","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":1016},{"nctId":"NCT03454841","phase":"","title":"Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor","status":"COMPLETED","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2018-02-26","conditions":"Acute Myocardial Infarction","enrollment":73},{"nctId":"NCT02978040","phase":"PHASE4","title":"Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2017-07-04","conditions":"Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction","enrollment":122},{"nctId":"NCT02376283","phase":"PHASE4","title":"P3AMI Antiplatelet Trial","status":"COMPLETED","sponsor":"The Royal Wolverhampton Hospitals NHS Trust","startDate":"2015-03-09","conditions":"Heart Attack","enrollment":87},{"nctId":"NCT01597375","phase":"PHASE2","title":"Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)","status":"COMPLETED","sponsor":"Elliot Israel, MD","startDate":"2012-08-31","conditions":"Asthma, Aspirin-Induced, Aspirin Exacerbated Asthma","enrollment":46},{"nctId":"NCT02285751","phase":"PHASE2","title":"High \"on Treatment\" Platelet Reactivity in the Intensive Care Unit","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2012-11","conditions":"Critical Illness","enrollment":200},{"nctId":"NCT02487732","phase":"PHASE4","title":"Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2015-07","conditions":"Acute Coronary Syndrome","enrollment":60},{"nctId":"NCT01510327","phase":"PHASE3","title":"PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2009-10","conditions":"Coronary Artery Disease","enrollment":22},{"nctId":"NCT03111420","phase":"NA","title":"Study of AggreGuide A-100 (ADP) Assay","status":"COMPLETED","sponsor":"Aggredyne, Inc.","startDate":"2017-01-09","conditions":"Risk Factor, Cardiovascular, Platelet Dysfunction Due to Drugs","enrollment":280},{"nctId":"NCT01641510","phase":"PHASE3","title":"PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2013-10","conditions":"Acute Coronary Syndromes","enrollment":70},{"nctId":"NCT01587651","phase":"PHASE4","title":"Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2012-03","conditions":"Coronary Artery Disease","enrollment":110},{"nctId":"NCT01930773","phase":"PHASE3","title":"Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2013-03","conditions":"Stable Angina","enrollment":150},{"nctId":"NCT01589978","phase":"PHASE4","title":"PROMUS Element Plus US Post-Approval Study","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2012-05","conditions":"Coronary Artery Disease","enrollment":2681},{"nctId":"NCT02422888","phase":"PHASE4","title":"Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor","status":"UNKNOWN","sponsor":"Amsterdam UMC, location VUmc","startDate":"2015-05","conditions":"Myocardial Infarction","enrollment":110},{"nctId":"NCT01612884","phase":"PHASE4","title":"Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)","status":"TERMINATED","sponsor":"Indiana University","startDate":"2011-08","conditions":"Thrombosis, Coronary Artery Disease","enrollment":67},{"nctId":"NCT03469856","phase":"NA","title":"Acetyl Salicylic Elimination Trial: The ASET Pilot Study","status":"UNKNOWN","sponsor":"Pedro A. Lemos","startDate":"2018-02-22","conditions":"Monotherapy After PCI","enrollment":200},{"nctId":"NCT01103440","phase":"PHASE2","title":"Aspirin Resistance and Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2007-04","conditions":"Stable Angina","enrollment":36},{"nctId":"NCT03273075","phase":"PHASE4","title":"Add-on Cangrelor in STEMI-triggered Cardiac Arrest","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2017-09","conditions":"Cardiopulmonary Arrest With Successful Resuscitation, ACS - Acute Coronary Syndrome, Hypothermia, Induced","enrollment":60},{"nctId":"NCT02075125","phase":"PHASE3","title":"Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction","status":"TERMINATED","sponsor":"Dong-A University","startDate":"2014-01","conditions":"ST-Segment Elevation Myocardial Infarction","enrollment":39},{"nctId":"NCT02808767","phase":"PHASE4","title":"Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2013-01","conditions":"Myocardial Infarction, Angioplasty, Balloon, Coronary, Platelet Aggregation Inhibitors","enrollment":1226},{"nctId":"NCT01531114","phase":"PHASE3","title":"PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus","status":"COMPLETED","sponsor":"Gennaro Sardella","startDate":"2013-05","conditions":"ST-Elevation Myocardial Infarction","enrollment":50},{"nctId":"NCT02215993","phase":"PHASE4","title":"Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2013-07","conditions":"Acute Coronary Syndrome, Platelet Function","enrollment":50},{"nctId":"NCT01789814","phase":"PHASE4","title":"Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-07","conditions":"Coronary Artery Disease","enrollment":24},{"nctId":"NCT02212028","phase":"PHASE4","title":"Pharmacological Effects of Crushing Prasugrel in STEMI Patients","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-10","conditions":"Coronary Artery Disease","enrollment":52},{"nctId":"NCT01852214","phase":"NA","title":"Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes","status":"COMPLETED","sponsor":"University of Florida","startDate":"2013-02","conditions":"Diabetes Mellitus, Coronary Artery Disease","enrollment":50},{"nctId":"NCT02929888","phase":"PHASE2, PHASE3","title":"Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients","status":"UNKNOWN","sponsor":"Fundacion Investigacion Interhospitalaria Cardiovascular","startDate":"2016-10","conditions":"Acute Myocardial Infarction","enrollment":60},{"nctId":"NCT01700322","phase":"PHASE4","title":"Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study","status":"COMPLETED","sponsor":"Johannes Gutenberg University Mainz","startDate":"2012-08","conditions":"Coronary Artery Disease","enrollment":126},{"nctId":"NCT01790854","phase":"PHASE4","title":"BLeeding Events and Maintenance DoSe of PraSugrel","status":"TERMINATED","sponsor":"David Antoniucci","startDate":"2012-11","conditions":"Adverse Reaction to Antiplatelet Agent, Acute Coronary Syndrome","enrollment":195},{"nctId":"NCT01327534","phase":"PHASE3","title":"Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI","status":"COMPLETED","sponsor":"Stiftung Institut fuer Herzinfarktforschung","startDate":"2011-05","conditions":"Myocardial Infarction, STEMI","enrollment":63},{"nctId":"NCT02507323","phase":"PHASE2","title":"Ticagrelor vs. Prasugrel Effects on Infarct Size","status":"WITHDRAWN","sponsor":"Yochai Birnbaum","startDate":"2016-02","conditions":"Cardiovascular Disease","enrollment":""},{"nctId":"NCT01852175","phase":"NA","title":"Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease","status":"COMPLETED","sponsor":"University of Florida","startDate":"2012-01","conditions":"Coronary Artery Disease","enrollment":110},{"nctId":"NCT02108808","phase":"PHASE4","title":"Effect of Ticagrelor on Fractional Flow Reserve","status":"COMPLETED","sponsor":"University of Patras","startDate":"2014-04","conditions":"Fractional Flow Reserve","enrollment":76},{"nctId":"NCT01609647","phase":"PHASE3","title":"Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-09","conditions":"Acute Coronary Syndrome","enrollment":76},{"nctId":"NCT01493999","phase":"PHASE4","title":"Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity","status":"COMPLETED","sponsor":"University of Pecs","startDate":"2011-09","conditions":"Acute Coronary Syndrome","enrollment":147},{"nctId":"NCT01510171","phase":"PHASE4","title":"Rapid Activity of Platelet Inhibitor Drugs Study","status":"COMPLETED","sponsor":"Careggi Hospital","startDate":"2012-01","conditions":"ST-segment Elevation Myocardial Infarction","enrollment":50},{"nctId":"NCT01805570","phase":"PHASE4","title":"Rapid Activity of Platelet Inhibitor Drugs Study 2","status":"COMPLETED","sponsor":"David Antoniucci","startDate":"2012-11","conditions":"Myocardial Infarction","enrollment":50},{"nctId":"NCT01684813","phase":"PHASE4","title":"VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2012-10","conditions":"Diabetes Mellitus Type II, Acute Coronary Syndrome","enrollment":65},{"nctId":"NCT01339026","phase":"PHASE4","title":"Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention","status":"TERMINATED","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2012-02","conditions":"Cardiovascular Disease, Acute Coronary Syndrome","enrollment":44},{"nctId":"NCT02243137","phase":"PHASE1","title":"Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate","status":"COMPLETED","sponsor":"David Vivas","startDate":"2013-05","conditions":"Adverse Effect of Antithrombotic Drugs","enrollment":30},{"nctId":"NCT01839968","phase":"","title":"Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2011-09","conditions":"Acquired Platelet Disorder","enrollment":32},{"nctId":"NCT01408121","phase":"","title":"African-American Pharmacogenetics","status":"UNKNOWN","sponsor":"Medstar Health Research Institute","startDate":"2011-11","conditions":"Acute Coronary Syndrome","enrollment":200},{"nctId":"NCT01177592","phase":"NA","title":"Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)","status":"TERMINATED","sponsor":"LifeBridge Health","startDate":"2010-07","conditions":"Coronary Artery Disease","enrollment":7},{"nctId":"NCT01015287","phase":"PHASE3","title":"A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-12","conditions":"Acute Coronary Syndromes","enrollment":4033},{"nctId":"NCT02070159","phase":"PHASE3","title":"Prasugrel With Lower Dose - Loading Dose","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2011-12","conditions":"Coronary Artery Disease","enrollment":43},{"nctId":"NCT02032303","phase":"PHASE4","title":"Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .","status":"UNKNOWN","sponsor":"Azienda Policlinico Umberto I","startDate":"2014-02","conditions":"Acute Coronary Syndrome, Non ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction","enrollment":88},{"nctId":"NCT00976092","phase":"PHASE4","title":"Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction","status":"UNKNOWN","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2009-09","conditions":"Myocardial Infarction","enrollment":548},{"nctId":"NCT01456364","phase":"PHASE4","title":"Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing","status":"UNKNOWN","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2011-09","conditions":"Coronary Heart Disease","enrollment":70},{"nctId":"NCT01835353","phase":"PHASE3","title":"High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"University of Patras","startDate":"2012-06","conditions":"Platelet Reactivity","enrollment":82},{"nctId":"NCT00699998","phase":"PHASE3","title":"A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-06","conditions":"Acute Coronary Syndrome","enrollment":9326},{"nctId":"NCT01201772","phase":"PHASE4","title":"Prasugrel Re-load Strategies","status":"COMPLETED","sponsor":"University of Florida","startDate":"2010-08","conditions":"Coronary Artery Disease","enrollment":65},{"nctId":"NCT01115738","phase":"PHASE2","title":"Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-05","conditions":"Acute Coronary Syndrome","enrollment":282},{"nctId":"NCT01336348","phase":"PHASE3","title":"Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2010-04","conditions":"ST Segment Elevation Myocardial Infarction","enrollment":100},{"nctId":"NCT01591317","phase":"PHASE1","title":"Study of Prasugrel in Korean Healthy Male Volunteers","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-03","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT00910299","phase":"PHASE2","title":"Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2009-07","conditions":"Coronary Artery Disease (CAD)","enrollment":423},{"nctId":"NCT01107899","phase":"PHASE1","title":"Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2009-10","conditions":"Acute Coronary Syndromes","enrollment":29},{"nctId":"NCT00830960","phase":"PHASE3","title":"A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-02","conditions":"Acute Coronary Syndrome","enrollment":720},{"nctId":"NCT01338909","phase":"PHASE3","title":"Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)","status":"COMPLETED","sponsor":"University of Patras","startDate":"2011-04","conditions":"Myocardial Infarction","enrollment":35},{"nctId":"NCT01212302","phase":"NA","title":"Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2008-10","conditions":"Coronary Artery Disease","enrollment":500},{"nctId":"NCT01099566","phase":"PHASE4","title":"The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2009-11","conditions":"Healthy Volunteers, Sepsis","enrollment":20},{"nctId":"NCT01090336","phase":"","title":"Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)","status":"UNKNOWN","sponsor":"Heidelberg University","startDate":"2009-08","conditions":"Patients With Acute Coronary Syndrome","enrollment":26},{"nctId":"NCT00356135","phase":"PHASE2","title":"Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-07","conditions":"Coronary Arteriosclerosis, Acute Coronary Syndrome","enrollment":139},{"nctId":"NCT00097591","phase":"PHASE3","title":"A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2004-11","conditions":"Coronary Arteriosclerosis, Acute Coronary Syndromes","enrollment":13619},{"nctId":"NCT00385944","phase":"PHASE2","title":"The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-03","conditions":"Acute Coronary Syndrome","enrollment":56},{"nctId":"NCT00357968","phase":"PHASE2","title":"Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-08","conditions":"Coronary Artery Disease","enrollment":201},{"nctId":"NCT01158846","phase":"PHASE4","title":"Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI","status":"UNKNOWN","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2010-08","conditions":"ST-Elevation Myocardial Infarction, Primary Percutaneous Coronary Intervention","enrollment":800},{"nctId":"NCT00059215","phase":"PHASE2","title":"A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2003-04","conditions":"Cardiovascular Diseases, Heart Diseases","enrollment":905},{"nctId":"NCT01103843","phase":"NA","title":"Plavix, Prasugrel and Drug Eluting Stents Pilot Trial","status":"UNKNOWN","sponsor":"St. Francis Hospital, New York","startDate":"2010-04","conditions":"Coronary Artery Disease, Platelet Aggregation Inhibitors, PCI- Percutaneous Coronary Intervention","enrollment":1000},{"nctId":"NCT00642174","phase":"PHASE2","title":"Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-04","conditions":"Diabetes Mellitus, Coronary Artery Disease","enrollment":35}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Effient"],"phase":"marketed","status":"active","brandName":"Prasugrel loading","genericName":"Prasugrel loading","companyName":"Azienda Policlinico Umberto I","companyId":"azienda-policlinico-umberto-i","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prasugrel is a thienopyridine antiplatelet agent that irreversibly inhibits the P2Y12 adenosine diphosphate receptor on platelets, preventing platelet aggregation. Used for Acute coronary syndrome (ACS) including unstable angina, non-ST elevation myocardial infarction (NSTEMI), and ST elevation myocardial infarction (STEMI) managed with percutaneous coronary intervention (PCI).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}